Monash University, ranked among the top three global universities for pharmacy and pharmacology from 2016 to 2024, is home to the Monash Institute of Pharmaceutical Sciences (MIPS), a global leader in end-to-end drug discovery and development. MIPS collaborates with local and international academic and industry partners to address health challenges including cardiovascular disease, psychiatric conditions and global health challenges such as infectious diseases and maternal health, aiming to enhance drug efficacy and outcomes for individuals, families and communities.

Find out more here.

The University of Sydney’s Centre for Drug Discovery Innovation is a multidisciplinary research centre with capabilities ranging from fundamental biology to preclinical evaluation. We integrate drug discovery expertise across the University to discover new targets and design novel molecules with high potential for industry uptake and translation. The Centre partners with academic, healthcare, and industry leaders to translate research into real-world treatments for diseases such as cancer, infectious diseases, and neurological disorders.

Find out more here.

WEHI is where the world’s brightest minds collaborate and innovate to make life-changing scientific discoveries that help people live healthier for longer. Our medical researchers have been serving the community for more than 100 years, making transformative discoveries towards solving some of the world’s most complex health problems. The National Drug Discovery Centre (NDDC) at WEHI provides Australian researchers with cutting-edge facilities and expertise in high-throughput screening, helping them overcome critical early challenges in drug discovery. At WEHI, we are brighter together.

Find out more here.